Document 8naxy8n9xQ6DoJJja0VeM36d

FILE NAME: CTFA (CTFA) DATE: 1976 Mar 11 DOC#: CTFA008 DOCUMENT DESCRIPTION: Meeting Minutes-CTFA Talc Task Force N ____ ._____ -- - ... . The Cosmetic, Toiletry and Fragrance Association, Inc. 113515th STREET; N.W., WASHINGTON, D.C. 20005 202/331-1770 *TELEX 8^-2673 Jame H. U e rA W Norman P, Estiin. Ph D, We# trttrt- lyysjtf t b s CTTA TALC TASK FORCE A meeting of -theCTFA Talc Task-Force was held on March 11th, 1976 i at th CTFA offices in Washington, D.C. Those in attendance were: George Sandland, Briial-Myers Company (Chairman) Joha.B* lments 'Pfizer* ine* Ray ;Krairliner Whittaker Cleirk & Daniels George, Lee, JohhsA Johnson Baby Products Company Monroe Massinger, Chesebrough-Pohd s Xnc.* .'Roderick , -Mundy / Sterling-Drug Inc. Louis . Murino . Cyprus Industrial Minerals Company 'D*R*'Fetterson.' JohnsOn & Johnson Baby Products company Fred Roe sch Whittaker* Clark & Daniels Robert Rolle, Johnson & -Johnson Baby Products Company John P, Shiz/' Johnson S `Johnson Baby Products Company Maurice Siegel, Pbrge, inoJ.C-# /Sixnkoy r,,* , Colgate-Palml ive' Company Harold; Stanley, Pfizer, Ine. * Ian Stewart; Walter C. Mcrne Associates. Robert Suffis, The Mennen Company S. Thompson,. R.T-.Vanderbilt & Company John J. Travers, Avon Products, Inc* William* c ;-Waggoner, Johnson & Johnson .Baby Products Company Norman F. strin, `.CTFA * Mr, Sandland opened the .-meeting and proceeded with th& agenda. I, Status Review ,. / * V* * A-"' iTalc Standards, and Methods Copies pf th- proposed specification and methods, plus copies'of a :letter -to Dr. Schaffner vere distributed . t task force members, - . . V. * * y-"'. * -B. A -status.report-(dated March 8fch,. 197$), prepared by.. Dt# Petterson#-, on cosmetic talc stetas whs distributed 1 to those presemi. X copy of ah article V 1 CONTINUED 0 `EXT PAGE P ___ D___ Ex. N o.:. Deponent: Vj- M u S ^ S B D a te :. ---- Shirley Q- Cavilan, CSR No. 12361 EXHlBlfttlJf__ j DTEiJ^nrS^ i G. LUCAS, RPR, RMR, CRR, CLR Dr- Kohl .arid Dr- Arthur M. Langer on. "Identification and Quantitation pf Asbestos in Taie*' was distributed 'it appears in Environmental health Perspectives,. Volume bt 1974, pp, 95-109. .Also, a copy bfthe 'correction to the March-8, .1976 Washington Post article on talc and;the summary;of the.draft Talk jpaper anticipated from the FDA was distributed to those present'. l\ ' V , * p C. Iiwin,amples. A 9 . Mr.- Sandiand Summarized-the Contents'pf the November, 197.5 letter from fienfy Davis (FDA) revesting CTFA hgply Its methodology.to several* of Dr. Lewin samples provided on a coded-basis. The rsiits of the analyss were described bv Dr. .fcolle, 2. Mt.Slhal Analysed on.Old Production gazoles Dr.Pettrsoh gave detailed background -on Dr .Lunger's work. He' stated the objective of the .task.force should be to de velop and. collate data that would ..lead tp a prsentacion b beffe. the Miscellaneous External Panel,-,in.*order to attempt to have talc placed in Category I. ,The rsulte of Dr* Pooley*s analyses* sponsored by Johnson fi Johnson/, were summarized. .It'was reported.that' Dr. tancer -performed his anavises on sam ples- purchased in 197.3. Mr. Simko described a meetini .between himself nd Dr* Lancer oh. Tuesday. He estimated the sample of "Cashmere Bpucuet" tsbd was probably a. pre-1970 sample. . Mr.-Mundy (Sterling) reported O n his contacts with Dr. Langer and .stated the ample Dr. Langer tested was from 1970 production. , * * *. k*. , 3. fteeent Production Data It was agreed toy. the. task force that .it would be extreme)y beneficial if induVidua! companies- could provide data to the FDA .on recent production.,/Most companies present indicated that-they possess such data, and would bp willing to -provide the data. Mri Messihcer (Chesebrough^POnd's) statsd hu y: would have to confirm this willingness with his management. It was-suggested each' company 'prepare a-;let ter,, addressed to Dr. Estrin, with a summai^ of*the data on recent* production for .thir 'products and a commitment to set-up a subsquent 1 meeting with FDA- to discuSs this data, in detail, if FDA so desires. This, letter -should be delivered t Dr. Estrin by Monday,'March i5th. Subsequently, a meeting was set-up for that Monday, March 15th, it* the CTFA offic.es, with a meeting at FDA to .be held in ;the afternoon.'. i 4. CTFA Study on Current. Production * ^ 4 .| ** * *> * Advantages and disadvantages- of haying CTFA contr act an in dependent laboratory-to do tests on current productioi sam ples was discussed.* It Was noted that, such data Would no * doubt be useful, hot only in discussions with FDA, but Iso as part of a presentation to tbe Miscellaneous External Fane) and, perhaps, to ether panels as well* it was suggested the CTF methodology b utilized for such a task, but that TEM be used on those *samples that have ben 'shown to be positive CONTINUED ON NEXT PAGE f PCSTf .U W I N # PRODUCT ...... . 1318 1339 1340 13.41 1342 1343 1344 1345 1346 1.347 1.348 1349 T35Q 1351 1352 l? 77 96 97 101 i02A 143 144B 151 154 15 7 A 160 163 75 173A .Lady Ester Face Powder Rachel Touch and Blow Face Powder Blanchard's Dusting Powder Born Wild Dusting Powder, Del Labs Ta1 Winds Spray Talc, Avon Tosca Dusting Powder Pin-Zow Talque, Perf. Beauty Prod. Overton's."High Brown" Face Powder .Early American Old .Spice Talcum Powder Bismoline Medicated Powder Mavis. Imported Talcum Avon Beauty. Dust Refill Charisma Pinaud. Clubman Talc OH1 de London Talc; .Yardley Corsage Dusting Powder TREKUTE UHliT C'ST CHttYS&TllE IE8TF"' r5T ND 2,800 f/ing. ND ND 3 5*500 ND 7 8 f 13,000 10 * 12 60,000 15 ND 15 8,900 ND ND 10 1,800 7 ND 5 400 10 - 5 ND ? ND ND 2,000 ND - 2 9,000 ND - 6 ND 8 ND NB 9,000 trace ND 10 ? 10 - ND - ND 7 ND NO ? ? b y C T F A methodology and aiso be performed on a random basis on other/saagples.. company representatives were polled at this meeting and. previously by Mr, George Lee to determine whethor they would* be. willing #o. participate in such n study by assur ing* that current production samples would be provided and that financial support, would be"given. The results Would be made known to the PDA add probably published in some Corn. The following companies indicated they would be willing to parti cipates Avon.Products, Inc* Bribtol-Myers Company Colgate-Palmolive Company Coty,'ihc. Faberge*. Inc. , Johnson & Johnsori Hennen Sterling , , In addition, Che sebrough-Pond 's , Mem,' and Yard ley would probably be. Interested. The* task force -agreed to await the results of the m e e t i n a s with CTFA before deciding on whether a study on current produc tion should be initiated. The meeting adjourned in order for a.small group to meet with FDA at 2 s00 p.Jfi. to discuss the results of CTFA analyses of Dr. Lew in* s samples. orman s Estrin, Ph.'D, Vice President - Science KFE.jj March 12th, 1976